Literature DB >> 23137713

Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide.

Caterina Foti, Annarita Antelmi, Antonio Mazzocca, Francesco Saverio Vella, Paolo Romita, Stefania Pugliese, Daniela Lomazzo, Piero Portincasa, Giuseppe Palasciano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23137713     DOI： 10.1684/ejd.2012.1853

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  4 in total

1.  Highly Probable Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Lenalidomide.

Authors:  Anusha Shanbhag; E Ryan Pritchard; Kshitij Chatterjee; Drayton A Hammond
Journal:  Hosp Pharm       Date:  2017-07-18

2.  Patient with refractory multiple myeloma developing eosinophilia after lenalidomide treatment and lung cancer 9 months later: case report and review of the literature.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Hidenori Imai; Mutsumi Wakabayashi; Keiji Sugimoto; Noriko Nakamura; Tomohiro Sawada; Norio Komatsu; Masaaki Noguchi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-03-14       Impact factor: 0.900

Review 3.  Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Caused by Lenalidomide: Case Report and Review of the Literature.

Authors:  Shin-Ichi Osada; Takahiko Sato
Journal:  Acta Derm Venereol       Date:  2021-05-28       Impact factor: 3.875

4.  Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.

Authors:  Mauro Grandolfo; Paolo Romita; Domenico Bonamonte; Gerardo Cazzato; Katharina Hansel; Luca Stingeni; Claudio Conforti; Roberta Giuffrida; Caterina Foti
Journal:  Dermatol Ther       Date:  2020-05-22       Impact factor: 2.851
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.